Childhood acute lymphoblastic leukemia: Prognostic value of initial peripheral blast count in good responders to prednisone

American Journal of Pediatric Hematology/Oncology

Volumn 23, Issue 7, 2001, Pages 411-415

  Felice, María S ^a   Zubizarreta, Pedro A ^a   Alfaro, Elizabeth M ^a   Sackmann Muriel, Federico ^a  

^a HOSPITAL DE PEDIATRÍA PROF DR JUAN P GARRAHAN   (Argentina)

Author keywords

Acute lymphoblastic leukemia; Children; Initial peripheral blast count; Prednisone good response; Prognostic factors; Steroids

Indexed keywords

METHOTREXATE; PREDNISONE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ARTICLE; BLAST CELL; CANCER RECURRENCE; CANCER REGRESSION; CANCER SURVIVAL; CHILD; CHILDHOOD LEUKEMIA; DRUG RESPONSE; FEMALE; FOLLOW UP; HUMAN; IMMUNOPHENOTYPING; INFANT; MAJOR CLINICAL STUDY; MALE; MEDIASTINUM LYMPH NODE; PRIORITY JOURNAL; PROGNOSIS; SPLEEN; T LYMPHOCYTE SUBPOPULATION;

ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLAST CRISIS; CHILD; CHILD, PRESCHOOL; DISEASE-FREE SURVIVAL; DRUG RESISTANCE, NEOPLASM; FEMALE; HUMANS; INFANT; LEUKEMIA, LYMPHOCYTIC, ACUTE; LEUKOCYTE COUNT; MALE; METHOTREXATE; PREDNISONE; PROGNOSIS; REMISSION INDUCTION; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0034760284     PISSN: 01928562     EISSN: None     Source Type: Journal    
DOI: 10.1097/00043426-200110000-00004     Document Type: Article

References (14)

1. Pui Ch-H, Evans W. Acute lymphoblastic leukemia. N Engl J Med 1998; 339: 605-15.
2. Smith M, Arthur D, Camitta B, et al. Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia. J Clin Oncol 1996; 14: 18-24.
3. Steinherz PG, Gaynon PS, Breneman JC, et al. Cytoreduction and prognosis in acute lymphoblastic leukaemia. The importance of early marrow response: report from the Children’s Cancer Group. J Clin Oncol 1996; 14: 389-98.
4. Gaynon PS, Desai AA, Bostrom BC, et al. Early response to therapy and outcome in childhood acute lymphoblastic leukemia. A review. Cancer 1997; 80: 1717-26.
5. Gajjar A, Ribeiro R, Hancock ML, et al. Persistence of circulating blasts after 1 week of multiagent chemotherapy confers a poor prognosis in childhood acute lymphoblastic leukemia. Blood 1995; 86: 1292-5.
6. Riehm H, Gadner H, Henze G, et al. Results and significance of six randomized trials in four consecutive ALL-BFM studies. Hematol Blood Transfusion 1990; 33: 439-50.
7. Reiter A, Schrappe M, Ludwig WD, et al. Chemotherapy in 998 unselected childhood acute lymphoblastic leukemia patients. Results and conclusions of the Multicenter Trial ALL-BFM86. Blood 1994; 84: 3122-33.
8. Sackmann-Muriel F, Felice M, Zubizarreta P, et al. Treatment results in childhood acute lymphoblastic leukemia with a modified ALL-BFM’90 protocol: lack of improvement in high-risk group. Leukemia Res 1999; 23: 331-40.
9. Bene MC, Castoldi G, Knapp W, et al. Proposals for the immunological classification of acute leukemias. Leukemia 1995; 9: 1783-6.
10. Williams DL, Harris A, Williams KJ, et al. A direct bone marrow chromosome technique of acute lymphoblastic leukemia. Cancer Genet Cytogenet 1984; 13: 239-57.
11. Schrappe M, Reiter A, Ludwig W-D, et al. Improved outcome in childhood acute lymphoblastic leukemia despite reduced use of anthracyclines and cranial radiotherap. Results of trial ALL-BFM 90. Blood 2000; 95: 3310-22.
12. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-81.
13. Peto R, Pike MC, Armitage P, et al. Design and analysis of randomized clinical trials requiring prolonged observation on each patient. II. Analysis and examples. Br J Cancer 1977; 35: 1-39.
14. Tarone RE, Wara J. On distribution-free test for equality of survival distribution. Biometrika 1977; 64: 156-60.